
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
COVID-19 and autoimmune diseases
Yu Liu, Amr H. Sawalha, Qianjin Lu
Current Opinion in Rheumatology (2020) Vol. 33, Iss. 2, pp. 155-162
Open Access | Times Cited: 441
Yu Liu, Amr H. Sawalha, Qianjin Lu
Current Opinion in Rheumatology (2020) Vol. 33, Iss. 2, pp. 155-162
Open Access | Times Cited: 441
Showing 1-25 of 441 citing articles:
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination
Abdulla Watad, Gabriele De Marco, Hussein Mahajna, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 435-435
Open Access | Times Cited: 349
Abdulla Watad, Gabriele De Marco, Hussein Mahajna, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 435-435
Open Access | Times Cited: 349
The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19
Christoph Schultheiß, Edith Willscher, Lisa Paschold, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 6, pp. 100663-100663
Open Access | Times Cited: 322
Christoph Schultheiß, Edith Willscher, Lisa Paschold, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 6, pp. 100663-100663
Open Access | Times Cited: 322
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 224
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 224
The Conundrum of ‘Long-COVID-19ʹ: A Narrative Review
Mandeep Garg, Muniraju Maralakunte, Suruchi Garg, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 2491-2506
Open Access | Times Cited: 186
Mandeep Garg, Muniraju Maralakunte, Suruchi Garg, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 2491-2506
Open Access | Times Cited: 186
Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis
Anuraag Jena, Shubhra Mishra, Parakkal Deepak, et al.
Autoimmunity Reviews (2021) Vol. 21, Iss. 1, pp. 102927-102927
Open Access | Times Cited: 168
Anuraag Jena, Shubhra Mishra, Parakkal Deepak, et al.
Autoimmunity Reviews (2021) Vol. 21, Iss. 1, pp. 102927-102927
Open Access | Times Cited: 168
The humoral response and antibodies against SARS-CoV-2 infection
Hai Qi, Bo Liu, Xinquan Wang, et al.
Nature Immunology (2022) Vol. 23, Iss. 7, pp. 1008-1020
Open Access | Times Cited: 150
Hai Qi, Bo Liu, Xinquan Wang, et al.
Nature Immunology (2022) Vol. 23, Iss. 7, pp. 1008-1020
Open Access | Times Cited: 150
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus
Wenjuan Dong, Heather Mead, Lei Tian, et al.
Journal of Virology (2021) Vol. 96, Iss. 1
Open Access | Times Cited: 142
Wenjuan Dong, Heather Mead, Lei Tian, et al.
Journal of Virology (2021) Vol. 96, Iss. 1
Open Access | Times Cited: 142
Mast cell activation symptoms are prevalent in Long-COVID
Leonard B. Weinstock, Jill Brook, Arthur S. Walters, et al.
International Journal of Infectious Diseases (2021) Vol. 112, pp. 217-226
Open Access | Times Cited: 137
Leonard B. Weinstock, Jill Brook, Arthur S. Walters, et al.
International Journal of Infectious Diseases (2021) Vol. 112, pp. 217-226
Open Access | Times Cited: 137
NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond
Yuanfeng Zhu, Xiaoli Chen, Xin Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 137
Yuanfeng Zhu, Xiaoli Chen, Xin Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 137
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes
Banafsheh Bigdelou, Mohammad Reza Sepand, Sahar Najafikhoshnoo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 93
Banafsheh Bigdelou, Mohammad Reza Sepand, Sahar Najafikhoshnoo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 93
High risk of autoimmune diseases after COVID-19
Chetan Sharma, Jagadeesh Bayry
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 7, pp. 399-400
Open Access | Times Cited: 83
Chetan Sharma, Jagadeesh Bayry
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 7, pp. 399-400
Open Access | Times Cited: 83
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
Aristo Vojdani, Elroy Vojdani, Evan Saidara, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 400-400
Open Access | Times Cited: 82
Aristo Vojdani, Elroy Vojdani, Evan Saidara, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 400-400
Open Access | Times Cited: 82
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review
Yhojan Rodríguez, Manuel Rojas, Santiago Beltrán, et al.
Journal of Autoimmunity (2022) Vol. 132, pp. 102898-102898
Open Access | Times Cited: 81
Yhojan Rodríguez, Manuel Rojas, Santiago Beltrán, et al.
Journal of Autoimmunity (2022) Vol. 132, pp. 102898-102898
Open Access | Times Cited: 81
Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study
Falko Tesch, Franz Ehm, Annika Vivirito, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 10, pp. 2905-2914
Open Access | Times Cited: 77
Falko Tesch, Franz Ehm, Annika Vivirito, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 10, pp. 2905-2914
Open Access | Times Cited: 77
Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19
Sung Ha Lim, Hyun Jeong Ju, Ju Hee Han, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2336120-e2336120
Open Access | Times Cited: 69
Sung Ha Lim, Hyun Jeong Ju, Ju Hee Han, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2336120-e2336120
Open Access | Times Cited: 69
The role of oxidative stress in the pathogenesis of infections with coronaviruses
Chandrima Gain, Sihyeong Song, Tyler Angtuaco, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 66
Chandrima Gain, Sihyeong Song, Tyler Angtuaco, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 66
Postacute Sequelae of SARS-CoV-2 in Children
Suchitra Rao, Rachel S. Gross, Sindhu Mohandas, et al.
PEDIATRICS (2024) Vol. 153, Iss. 3
Closed Access | Times Cited: 46
Suchitra Rao, Rachel S. Gross, Sindhu Mohandas, et al.
PEDIATRICS (2024) Vol. 153, Iss. 3
Closed Access | Times Cited: 46
Characterizing Long COVID in Children and Adolescents
Rachel S. Gross, Tanayott Thaweethai, Lawrence C. Kleinman, et al.
JAMA (2024) Vol. 332, Iss. 14, pp. 1174-1174
Closed Access | Times Cited: 23
Rachel S. Gross, Tanayott Thaweethai, Lawrence C. Kleinman, et al.
JAMA (2024) Vol. 332, Iss. 14, pp. 1174-1174
Closed Access | Times Cited: 23
Immunological and virological triggers of type 1 diabetes: insights and implications
Joana Lemos, Khemraj Hirani, Matthias von Herrath
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 20
Joana Lemos, Khemraj Hirani, Matthias von Herrath
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 20
Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases
Marcia Friedman, Jeffrey R. Curtis, Kevin Winthrop
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 10, pp. 1255-1265
Open Access | Times Cited: 98
Marcia Friedman, Jeffrey R. Curtis, Kevin Winthrop
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 10, pp. 1255-1265
Open Access | Times Cited: 98
The mRNA COVID-19 vaccine – A rare trigger of autoimmune hepatitis?
Cathy McShane, Clifford Kiat, Jonathan Rigby, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 5, pp. 1252-1254
Open Access | Times Cited: 86
Cathy McShane, Clifford Kiat, Jonathan Rigby, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 5, pp. 1252-1254
Open Access | Times Cited: 86
Long COVID from rheumatology perspective — a narrative review
Hem Sapkota, Arvind Nune
Clinical Rheumatology (2021) Vol. 41, Iss. 2, pp. 337-348
Open Access | Times Cited: 75
Hem Sapkota, Arvind Nune
Clinical Rheumatology (2021) Vol. 41, Iss. 2, pp. 337-348
Open Access | Times Cited: 75
Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
Enver Avcı, Fatma Abasiyanik
Journal of Autoimmunity (2021) Vol. 125, pp. 102745-102745
Open Access | Times Cited: 69
Enver Avcı, Fatma Abasiyanik
Journal of Autoimmunity (2021) Vol. 125, pp. 102745-102745
Open Access | Times Cited: 69
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine
Janaína Jamile Ferreira Saraceno, Guilherme Macedo Souza, Luciana Peixoto dos Santos Finamor, et al.
International Journal of Retina and Vitreous (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 58
Janaína Jamile Ferreira Saraceno, Guilherme Macedo Souza, Luciana Peixoto dos Santos Finamor, et al.
International Journal of Retina and Vitreous (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 58